Integral Diagnostics Limited (ASX:IDX)

Market Cap	928.05M -14.2%
Revenue (ttm)	627.22M +33.5%
Net Income	4.67M
EPS	0.02
Shares Out	372.71M
PE Ratio	165.31
Forward PE	19.74
Dividend	0.07 (2.59%)
Ex-Dividend Date	Aug 29, 2025

Volume	884,019
Average Volume	465,851
Open	2.560
Previous Close	2.510
Day's Range	2.470 - 2.560
52-Week Range	1.910 - 3.100
Beta	0.17
RSI	41.57
Earnings Date	Feb 23, 2026

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,025
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX